MKMin Kang

Min Kang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects

Research Interests


Min Kang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Chang-Ping Li

    Department of Digestive Diseases, Affiliated Hospital of Luzhou Medical College Luzhou, Sichuan, China

    1 shared publication
  • Lei Zhao

    Department of Digestive Diseases, The Second Affiliated Hospital of Haerbin Medical University Haerbin, China

    1 shared publication
  • Mei-Ping Ren

    Drug and Functional Food Center, Luzhou Medical College Luzhou, Sichuan, China

    1 shared publication
  • Ming-Ming Deng

    Department of Digestive Diseases, Affiliated Hospital of Luzhou Medical College Luzhou, Sichuan, China

    1 shared publication

Latest Publications

    • 15 November 2015
      • Vol. 7  (11) , 2212-22

    miR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1.

    by Min Kang, Mei-Ping Ren, Lei Zhao, Chang-Ping Li, Ming-Ming Deng

    MicroRNAs (miRNAs) play important roles in cancer progression including gastric cancer. miR-485-5p is reported as a potential suppressor in breast cancer, but its expression, cellular function and clinic features in gastric cancer is not known. In our study, we found that miR-485-5p expression was down-regulated in gastric cancer cell lines. miR-485-5p could inhibit gastric cancer cell growth in vitro and in vivo. We also found that miR-485-5p suppressed gastric cancer cell metastasis and sphere formation. It was confirmed flotillin-1 (Flot1) as a direct target of miR-485-5p, and up-regulation of miR-485-5p could decrease expression of Flot1 in gastric cancer cells. Further investigation showed that ectopic expression of Flot1 partially reversed the inhibition effect of enforced miR-485-5p expression on the malignant phenotypes of gastric cancer cells. The low expression of miR-485-5p in gastric cancer tissues was related to advanced clinical features and poorer prognosis. Our study suggested that miR-485-5p could be a potential prognostic marker and functions as a tumor suppressor in human gastric cancer by post-transcriptionally targeting Flot1.